Table 2 Evaluation metrics of three optimal models on F.ACE testing set

From: Plasma proteomic signatures associate with near-future Alzheimer’s disease dementia conversion in mild cognitive impairment patients

Model

Evaluation metrics on testing set

C-index

Median AUCs

Demographics model (model 0): SGB

0.68

0.71

Proteomics model (model 1): RSF + SGB

0.65

0.71

Demographics + Proteomics model (model 2): Lasso + SGB

0.69

0.75

Back to article page